San Francisco Bay Area biotech stories.
Friday, August 19, 2011
Four BioTime embryonic stem cell lines OK'd for NIH registry
Four embryonic stem cell lines developed by a subsidiary of BioTime Inc. were approved by the National Institute of Health for use by stem cell researchers in federally funded research, the company said Friday.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)